FDA Approved: FOSCAVIR — Supplemental Application (Clinigen Limited)

View source ↗

Summary

The FDA approves a supplemental application for FOSCAVIR (foscarnet sodium) filed by Clinigen Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acyclovir-resistant Herpes Simplex Virus Infection
• Cytomegalovirus Retinitis
• Varicella Zoster Virus Infection

Drugs mentioned

• FOSCAVIR (foscarnet sodium)

Snippet

SUPPL AP for FOSCAVIR (FOSCARNET SODIUM)